title: More effective immunosuppression with the use of FK506 after liver transplantation.
authors: Liver Disease Center, University of Hong Kong Medical Center, Queen Mary Hospital, Hong Kong, China.
authors: C M
authors: CM
authors: Lo
authors: S T
authors: ST
authors: Fan
authors: C L
authors: CL
authors: Liu
authors: I O
authors: IO
authors: Ng
authors: B K
authors: BK
authors: Lam
authors: B H
authors: BH
authors: Yong
authors: C L
authors: CL
authors: Lai
authors: G K
authors: GK
authors: Lau
authors: J
authors: J
authors: Wong
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology*; D008875:Middle Aged; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus